67 results
Page 2 of 4
8-K
EX-99.1
evy9hqehj 4j
7 Nov 22
Revolution Medicines Reports Third Quarter 2022 Financial Results and Update on Corporate Progress
4:08pm
424B5
1iuw1cbuefir39u
20 Jul 22
Prospectus supplement for primary offering
4:02pm
424B5
z2lo26 wmxs7zy
19 Jul 22
Prospectus supplement for primary offering
4:01pm
8-K
EX-99.1
fiz8iqpf6rf0p7e0hc
28 Feb 22
Revolution Medicines Reports Fourth Quarter and Year-End 2021 Financial Results and Update on Corporate Progress
4:06pm
8-K
EX-99.1
utcub oms2gno16o7d
11 Jan 22
Results of Operations and Financial Condition
2:16pm
424B5
ay88u38
10 Nov 21
Prospectus supplement for primary offering
4:31pm
8-K
EX-99.1
prnlaf2hn0 eqikhu
10 Nov 21
Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress
4:06pm
8-K
EX-99.1
bux6wu
11 Aug 21
Revolution Medicines Reports Second Quarter Financial Results and Update on Corporate Progress
4:06pm
8-K
EX-99.1
je1 7r30t0f7lt
10 May 21
Revolution Medicines Reports First Quarter Financial Results and Update on Corporate Progress
4:05pm
DEFA14A
3j3ypz2ejv q7jizoc5
3 May 21
Additional proxy soliciting materials
7:15am
S-3ASR
07gblt3515dlpc57c
2 Mar 21
Automatic shelf registration
4:38pm
8-K
EX-99.1
2vsquvbwbnstmo182j
2 Mar 21
Revolution Medicines Reports Fourth Quarter and Year-End 2020 Financial Results and Update on Corporate Progress
4:05pm